Search
BioCryst Pharmaceuticals Inc
BCRXAdd to Watchlist
8.470USD
-0.050-0.59%
Close 10-30 16:00（ET）
2.16BMarket Cap
LossP/E TTM
Today
-0.59%
5 Days
+10.72%
1 Month
+1.68%
6 Months
-7.53%
Year to Date
+8.59%
1 Year
+15.71%
Key Figures
8.550Open
8.617High
469.56KVolume
LossP/E TTM
12.68P/E Dynamic
--Dividend TTM
0.18%Turnover Ratio
8.520Prev. Close
8.380Low
3.97MTurnover
LossP/E Static
-4.76P/B
0.00%Div Yield TTM
-96.92%ROA
11.22052wk High
0.10Volume Ratio
-88.88MNet Profit
255.54MShares
-1.7226EPS TTM
0.58Beta
--ROE
6.23052wk Low
2.70%Amplitude
98.24%Gross Margin
2.16BMarket Cap
2.42Reward/Risk
3.03%Risk Rate
BioCryst Pharmaceuticals Inc's Score
0.01vs previous score
Forecast8.18
Financial Health8.68
Technical3.62
Valuation Dimensions8.52
Institutional Confidence10.00
Risk Assessment6.61
Media Coverage
Coverage Level
Very Low
Very High
Positive+
Analyst Rating
BioCryst Pharmaceuticals Inc Technical Analysis
Technical Indicators
Buy
Summary
Neutral
Moving Average
Neutral
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
0.31/0.12
Revenue / Forecast
218.25M/182.51M
BioCryst Pharmaceuticals Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolBCRX
Number of employees580
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| BlackRock Institutional Trust Company, N.A. | 6.67% |
| RA Capital Management, LP | 6.23% |
| Deerfield Management Company, L.P. | 5.64% |
| State Street Investment Management (US) | 4.80% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 32.51% |
| Investment Advisor/Hedge Fund | 25.27% |
| Hedge Fund | 21.44% |
| Venture Capital | 6.23% |
Related Instruments
+3.19%
-0.73%
+1.41%
+2.18%
-0.19%
+7.02%
+1.15%
+3.06%
+2.20%
+1.90%
+3.50%
+1.78%
+1.40%
+2.81%
+1.71%
+13.33%
-0.47%
+4.50%
-0.24%
-0.55%Popular Instruments
51788.900
-548.500 (-1.05%)
28406.600
-658.400 (-2.27%)
7583.100
-92.600 (-1.21%)
12785.000
-56.000 (-0.44%)
62328.000
-1656.000 (-2.59%)
6120.900
-77.700 (-1.25%)
102.428
+0.026 (+0.03%)
344.630
-4.280 (-1.23%)
204.640
-9.020 (-4.22%)
3874.710
-146.240 (-3.64%)
FAQs
What is the current price of BioCryst Pharmaceuticals Inc (BCRX)?
The current price of BioCryst Pharmaceuticals Inc (BCRX) is 8.47.
What is the symbol of BioCryst Pharmaceuticals Inc?
The ticker symbol of BioCryst Pharmaceuticals Inc is BCRX.
What is the 52-week high of BioCryst Pharmaceuticals Inc?
The 52-week high of BioCryst Pharmaceuticals Inc is 11.22.
What is the 52-week low of BioCryst Pharmaceuticals Inc?
The 52-week low of BioCryst Pharmaceuticals Inc is 6.23.
What is the market capitalization of BioCryst Pharmaceuticals Inc?
The market capitalization of BioCryst Pharmaceuticals Inc is 2.16B.
Is BioCryst Pharmaceuticals Inc (BCRX) currently rated as Buy, Hold, or Sell?
According to analysts, BioCryst Pharmaceuticals Inc (BCRX) has an overall rating of Buy, with a price target of 21.30.
What is the Earnings Per Share (EPS TTM) of BioCryst Pharmaceuticals Inc (BCRX)?
The Earnings Per Share (EPS TTM) of BioCryst Pharmaceuticals Inc (BCRX) is -1.72.